6393. What are the obligations of pharmaceutical companies in a global health emergency?
作者: Ezekiel J Emanuel.;Allen Buchanan.;Shuk Ying Chan.;Cécile Fabre.;Daniel Halliday.;Joseph Heath.;Lisa Herzog.;R J Leland.;Matthew S McCoy.;Ole F Norheim.;Carla Saenz.;G Owen Schaefer.;Kok-Chor Tan.;Christopher Heath Wellman.;Jonathan Wolff.;Govind Persad.
来源: Lancet. 2021年398卷10304期1015-1020页 6399. Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
作者: Rohini Mathur.;Christopher T Rentsch.;Caroline E Morton.;Rosalind M Eggo.;Krishnan Bhaskaran.;Laurie Tomlinsonn.;Liam Smeeth.;Ben Goldacre.
来源: Lancet. 2021年398卷10298期390页 |